Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Macrophages play a key role in responding to pathogens and initiate an inflammatory response to combat microbe multiplication. Deactivation of macrophages facilitates resolution of the inflammatory response. Deactivated macrophages are characterized by an immunosuppressive phenotype, but the lack of unique markers that can reliably identify these cells explains the poorly defined biological role of this macrophage subset. We identified lipocalin 2 (LCN2) as both a marker of deactivated macrophages and a macrophage deactivator. We show that LCN2 attenuated the early inflammatory response and impaired bacterial clearance, leading to impaired survival of mice suffering from pneumococcal pneumonia. LCN2 induced IL-10 formation by macrophages, skewing macrophage polarization in a STAT3-dependent manner. Pulmonary LCN2 levels were tremendously elevated during bacterial pneumonia in humans, and high LCN2 levels were indicative of a detrimental outcome from pneumonia with Gram-positive bacteria. Our data emphasize the importance of macrophage deactivation for the outcome of pneumococcal infections and highlight the role of LCN2 and IL-10 as determinants of macrophage performance in the respiratory tract.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It should be noted, however, that Lcn2 exerts contrasting effects depending on the pathogen and tissue localization, improving or mitigating resistance to infection.For example, Lcn2 aggravates the outcome of Streptococcus pneumoniae infection [134] through a immunomodulatory effect possibly acting via regulation of Fe metabolism or another not yet fully elucidated pathway [135,136].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [134]
In the citing paper
“LCN2 skews macrophages into an anti-inflammatory phenotype by increasing the formation of IL-10”
From Iron in immune cell function and host defense (2021) · cites this paper as [47]
In the citing paper
“extracellular bacteria may benefit from the action of LCN2, as its expression negatively affects the course of infections with S. pneumoniae”
From Iron in immune cell function and host defense (2021) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“In vitro, macrophages polarize to proinflammatory, classically activated M1 macrophages in the presence of IFN-γ and LPS, and to alternatively activated, antiinflammatory M2 macrophages in the presence of IL-4 and/or IL-13 (2, 8, 9).”
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 1×
“Deactivated macrophages are characterized by the downregulation of proinflammatory mediators and the upregulation of antiinflammatory cytokines such as IL-10 (10).”
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · cited 7×
“( D and E ) BMDMs were polarized with M1 (10 ng/ml LPS, 200 U/ml IFN-γ ) or M2 (10 ng/ml IL-4 and IL-13), activated with 10 ng/ml LPS (M x ), or deactivated (M dx ) with 10 ng/ml LPS and 100 μ M dexamethasone ( D and E ) or 10 ng/ml IL-10 ( D ) for 1, 6, and 16 hours.”
InfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“As such, further characterizations of alternative phenotypes resulted in the discovery of novel subsets, such as regulatory, deactivated, and tumor-associated macrophages (2, 9–11).”
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“Macrophages are innate immune cells involved in the maintenance of tissue homeostasis and in the pathogenesis of diverse conditions such as metabolic, allergic, fibrotic, autoimmune, and neoplastic diseases (1).”
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284 · cited 1×
“Upon analysis of the published LCN2 promoter (21) we noticed NF-κ B binding sites, but also glucocorticoid response elements and several binding sites for transcription factors critically involved in the polarization of M2 macrophages (22), such as STAT3, CREB, and C/EBP β .”
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098 · cited 1×
“LysMCre/Cre mice (47) were bred to STAT3flox/flox”
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960 · cited 1×
“In vitro, macrophages polarize to proinflammatory, classically activated M1 macrophages in the presence of IFN-γ and LPS, and to alternatively activated, antiinflammatory M2 macrophages in the presence of IL-4 and/or IL-13 (2, 8, 9).”
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., & Aderem, A. (2004) · Nature · doi:10.1038/nature03104 · Cited by 1,877 · cited 3×
“Lipocalin 2 (LCN2) (12, 13), also known as neutrophil gelatinase-associated lipocalin, is a mammalian protein expressed by myeloid and epithelial cells in response to TLR activation during infections (14, 15).”
The Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536
Research works printed but not linked: 1
- Zhang, 2008, Curr Protoc Immunol., Chapter 14, Unit14.1
Cited by
Items 101–149 of 149
Kuo, C., Hsieh, P., Chiu, V. J.-Y., Lan, C., & Lu, K. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/7736638 · Cited by 18
“IL-10 production by macrophages is induced by LCN-2, skewing macrophage polarization in a STAT3dependent manner [52].”
Sawatzky, J., Soo, J., Conroy, A. L., Bhargava, R., Namasopo, S., Opoka, R. O., & Hawkes, M. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002343 · Cited by 15
“0–11) Death [n (%)] 1 (3) 0 0 Transferred to another facility [n (%)] 1 (3) 0 2 (18) Withdrew from study [n (%)] 1 (3) 0 1 (9)”
Wang, Z., Zhou, X., Hu, X., & Zheng, C. (2023) · Journal of Applied Toxicology · doi:10.1002/jat.4566 · Cited by 13
An Integrative Analysis Identifying Transcriptional Features and key Genes Involved in COVID-19
Li, G., Wang, J., He, X., Zhang, L., Qin, R., Xiong, A., Wu, D., Hu, L., Song, Q., & Zhu, D. M. (2020) · Epigenomics · doi:10.2217/epi-2020-0168 · Cited by 14
COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts
Välikangas, T., Junttila, S., Rytkönen, K. T., Kukkonen-Macchi, A., Suomi, T., & Elo, L. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.929887 · Cited by 13
“Earlier studies have implicated LCN2 to deactivate macrophages, worsening the inflammatory response and negatively affecting the outcome of pneumococcal pneumonia (Warszawska et al., 2013).”
BackgroundDimopoulou, C. D., Guerra, P. R., Mortensen, M. S., Kristensen, K. A., Pedersen, M., Bahl, M. I., Sommer, M., Licht, T. R., & Laursen, M. F. (2024) · Scientific Reports · doi:10.1038/s41598-024-68412-9 · Cited by 12
Macrophage plasticity and differentiation on the decellularized human cornea
Chakraborty, J., Roy, S., Pandey, P. K., Mohanty, S., Tandon, R., & Ghosh, S. (2023) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/s43578-023-01182-8 · Cited by 11
“Emerging evidence indicates that lipocalin-2 is highly overexpressed under anti-inflammatory conditions and can downregulate the expression of MCP-1 and TNF-α [53, 54].”
BackgroundAmini‐Nik, S., Sadri, A.-R., Diao, L., Belo, C., & Jeschke, M. G. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0118-x · Cited by 11
Lei, W., Zeng, H., Feng, H., Ru, X., Li, Q., Xiao, M., Zheng, H., Chen, Y., & Zhang, L. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00391 · Cited by 10
“The results demonstrate that LCN2 (Warszawska et al., 2013) can effectively intervene in or treat SAH from a cell signaling pathway perspective.”
NLRP3 Triggers Attenuate Lipocalin-2 Expression Independent with Inflammasome Activation
Ahn, H., Lee, G., Kim, J., Park, J., Kang, S. G., Yoon, S., Lee, E., & Lee, G. (2021) · Cells · doi:10.3390/cells10071660 · Cited by 12
“LCN2 secretion from mice suffering from pneumococcal pneumonia inhibited the early phase of inflammation, leading to increased mortality [27].”
BackgroundHuber, A. K., & Irani, D. N. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00099 · Cited by 13
“Much has also been learned about host immune responses elicited by pneumococcal pneumonia or meningitis using mouse models (8, 9).”
BackgroundKaradağ, Z., Sehitoglu, T., Cüre, M. C., Rakıcı, H., Ayvaz, M. A., Bedir, R., Kızılkaya, B., Sahin, O. Z., & Cüre, E. (2018) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2018_057 · Cited by 10
“It was demonstrated that the secretion of NGAL had an antibacterial effect on the IL-6 expression in some bacterial infections, like streptococcus pneumonia (21).”
Chronic lung inflammation primes humoral immunity and augments antipneumococcal resistance
Boehme, J. D., Stegemann‐Koniszewski, S., Autengruber, A., Peters, N., Wissing, J. B., Jänsch, L., Jeron, A., & Bruder, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-05212-4 · Cited by 10
Saenz‐Pipaon, G., Jover, E., van der Bent, M. L., Orbe, J., Rodríguez, J. A., Fernández‐Celis, A., Quax, P. H. A., Páramo, J. A., López‐Andrés, N., Martín-Ventura, J. L., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117343 · Cited by 8
Growth arrest-specific protein 7 regulates the murine M1 alveolar macrophage polarization
Xu, Q., Liu, X., Wang, X., Hua, Y., Wang, X., Chen, J., Li, J., Wang, Y., Stoeger, T., Chen, S., et al. (2017) · Immunologic Research · doi:10.1007/s12026-017-8948-5 · Cited by 8
“pneumoniae can cause acute inflammatory response via inducing macrophage toward M1 polarization and releasing the pro-inflammatory cytokines [17].”
BackgroundLiu, D., Zhao, H., Zhao, L., Zhang, M.-J., Liu, T., Tao, B., Sun, L., & Liu, J. (2018) · Endocrine · doi:10.1007/s12020-017-1504-1 · Cited by 8
Akagha, M. J., Georgolopoulos, G., Martin, D., Meissl, K., Amenitsch, L., Vogl, C., Farlik, M., Fortelny, N., Halbritter, F., Müller, M. M., et al. (2026) · BMC Genomics · doi:10.1186/s12864-026-12601-5 · Cited by 9
“IRAK3 (also named IRAK-M) and LCN2 are both essential negative regulators of macrophage activity [48, 49].”
Self-citationEst-Witte, S. E., Shannon, S. R., Gong, D. H., Calabresi, K. G., Harris, J. J., Storm, K., Yoo, E., Isser, A., Jani, V., Livingston, N. K., et al. (2024) · Nano Research · doi:10.1007/s12274-024-6589-2 · Cited by 6
Paukszto, Ł., Mikołajczyk, A., Szeszko, K., Smolińska, N., Jastrzebski, J., & Kamiński, T. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.067 · Cited by 6
Jiang, S., Xu, Y., Wen, X., Zhang, Y., Chen, J., Han, Y., Zheng, Y., Qiao, X., Li, Y., Yu, H. B., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149021 · Cited by 5
An, H. S., Lee, J. W., Lee, S. J., Jeong, E. A., Shin, H. J., Kim, K. E., & Roh, G. S. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.02.029 · Cited by 5
Shen, D., & Chen, J. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01726-1 · Cited by 7
“Recent studies have shown that NGAL can promote the transformation of activated alveolar macrophages into a phenotype with high-level expression of IL-10 during Streptococcus pneumoniae infection [17].”
Indino, S., Borzi, C., Moscheni, C., Sartori, P., Cecco, L. D., Bernardo, G., Noci, V. L., Arnaboldi, F., Triulzi, T., Sozzi, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415802 · Cited by 6
“Since Lcn2 acts as an anti-inflammatory regulator of macrophage activation [59], it is possible to”
BackgroundInduction of Lipocalin2 in a Rat Model of Lung Irradiation
Sultan, S., Ahmad, S., Rave‐Fränk, M., Malik, I. A., Hess, C. F., Christiansen, H., & Cameron, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050637 · Cited by 4
“showed that LCN2 attenuated the early inflammatory response in a STAT-3-dependent manner by inducing IL-10 formation [18].”
BackgroundITRAQ-based quantitative proteomics analysis of forest musk deer with pneumonia
Tang, J., Suo, L., Li, F., Yang, C., Bian, K., & Wang, Y. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1012276 · Cited by 4
“LCN2 hindered the clearance of pneumococcal pneumonia and exacerbated pneumococcal pneumonia in mice and humans (40).”
BackgroundKapourchali, F. R., Glueck, B., Han, Y., Shapiro, D. B., Fulmer, C. G., & Cresci, G. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1851 · Cited by 5
Konrad, E. R., Soo, J., Conroy, A. L., Namasopo, S., Opoka, R. O., & Hawkes, M. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2160885 · Cited by 3
“Several studies have shown LCN2 to be elevated in patients with pneumonia, with higher levels associated with disease severity and poor outcomes [26,27].”
BackgroundCXCR2 perturbation promotes Staphylococcus aureus implant-associated infection
Akaraphanth, M., Nordgren, T. M., & Gries, C. M. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001821 · Cited by 2
“Lcn2 was previously shown to skew macrophages to a deactivated phenotype during pneumococcal pneumonia infection in mice by inducing IL-10 production and skewing macrophage polarization in a STAT3-dependent manner [34].”
BackgroundFriedlander, N. J., Burhans, M. S., Ade, L., O’Neill, L. M., Chen, X., & Ntambi, J. M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.035 · Cited by 2
Regulation of Iron and Its Significance in Obesity and Complications
Chan, Y. K., Sung, H. K., & Sweeney, G. (2014) · The Korean Journal of Obesity · doi:10.7570/kjo.2014.23.4.222 · Cited by 2
Does LCN2 Play a Critical Role in the Pathogenesis of Depression?
Liu, Y., Liu, X., Su, Y., Li, J., & Si, T. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107369 · Cited by 1
Abnormal Na+ transport by distal airway surface epithelia in cystic fibrosis swine
Grishchenko, N. (2018)
LCN2 aggravates diabetic cataracts by promoting ferroptosis in lens epithelial cells
Zhang, J., Sun, L., Yu, X., Yang, C., An, Q., Wei, C., & Ge, H. (2024) · Frigid Zone Medicine · doi:10.1515/fzm-2024-0018 · Cited by 1
Linking Transcriptional and Cellular Responses of Human and Murine Pneumococcal PneumoniaPreprint
Gorki, A.-D., Lakovits, K., Hladik, A., Mesteri, I., Gawish, R., Martins, R., Drobits, B., Menche, J., Knapp, S., & Stefanie Widder, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.13.638069
Self-citationBRIDGES, C. (2025) · Cronfa (Swansea University) · doi:10.23889/suthesis.69796
Prolonged skin allograft survival by rM180 amelogenin in a murine skin transplantation model
Shida, M., Sanui, T., Yotsumoto, K., Li, J., Ahmad, M., Xiao, M., Wang, Z., Hayashi, C., Nishimura, Y., Shinjo, T., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1663437
Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578028
Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578034
Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578031
Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578022
Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578019
Wang, D., Li, X., Jiao, D., Cai, Y., Qian, L., Shen, Y., Lu, Y., Zhou, Y., Fu, B., Sun, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578025
Rôle des cellules fœtales microchimériques dans la réparation maternelle
Sbeih, M. (2021) · theses.fr (ABES) · doi:10.70675/84da3df3z1d12z4899za64cz3cab779efd81
Le récepteur minéralocorticoide : une cible potentielle dans la fibrose intestinale ?
Amamou, A. (2020) · theses.fr (ABES) · doi:10.70675/ec2e0df7z8ae1z4feczaf08z10bcbd86d2f3
Julien, L. A. (2020) · theses.fr (ABES) · doi:10.70675/87fe6365z7ce8z43f8zbecbzf1b4ca746558 · Cited by 2
Lucaciu, A., Wurzel, P., Rasmussen, S. R., Lueckhoff, E., Mayser, F., Benjamin, J., Kestner, R., Haas, V. K., Huber, L. S., Bevara, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.23.733904
Suk, K. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118407
Guardado, S., Ojeda-Juárez, D., Ulu, A., Sveiven, S., Dominguez, E. C., Kim, S. Y., Patel, S., Kaul, M., & Nordgren, T. M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0359338
Metadata
- Authors
- Warszawska, J. M., Gawish, R., Sharif, O., Sigel, S., Doninger, B., Lakovits, K., Mesteri, I., Nairz, M., Boon, L., Spiel, A., Fuhrmann, V., Strobl, B., Müller, M., Schenk, P., Weiss, G., & Knapp, S.
- Affiliations
- Austrian Academy of Sciences (AT)
- Innsbruck Medical University (AT)
- Polpharma Biologics (Netherlands) (NL)
- Medical University of Vienna (AT)
- University of Veterinary Medicine Vienna (AT)
- Corresponding author
- Knapp, Sylvia
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2013-07-01
- Volume
- 123
- Issue
- 8
- Pages
- 3363-3372
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3726165
- OpenAlex
- W2029434160
- Cited by
- 148
- References
- 56
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 12 · 2023: 13 · 2022: 10 · 2021: 10 · 2020: 13 · 2019: 9 · 2018: 11 · 2017: 11 · 2016: 13 · 2015: 14 · 2014: 21
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Austrian Science Fund (SFB‐F28, I 289)
- Universität Wien
- Medizinische Universität Wien
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- neutrophil gelatinase-associated lipocalin, macrophage deactivation, pneumococcal pneumonia, Streptococcus pneumoniae, IL-10, STAT3 signaling, macrophage polarization, bacterial clearance, Gram-positive bacterial infections, immunosuppression, lung inflammation
- MeSH terms
- Lipocalin-2, Acute-Phase Proteins, Adult, Aged, Animals, Female, Humans, Immune Tolerance, Lung, Macrophage Activation, Male, Mice, Inbred C57BL, Middle Aged, Pneumonia, Pneumococcal, Proto-Oncogene Proteins, Oncogene Proteins, Macrophages, Alveolar, Interleukin-10, Transplantation Chimera, Mice, Knockout, Mice, Lipocalins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.